Altimmune (ALT) Net Income (2010 - 2026)
Altimmune (ALT) reported Net Income of -$22.83 million for Q2 2026, compared with -$22.15 million a year earlier.
Powered by 
Analysis
Altimmune (ALT) Net Income (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Altimmune's Net Income came in at -$91.76 million; for FY2025, it came in at -$88.09 million.
- By year, Net Income came in at -$95.06 million in FY2024, -$88.45 million in FY2023, -$84.71 million in FY2022 and -$97.09 million in FY2021.
- Five-year quarterly Net Income spans a low of -$33.51 million in Q3 2021 and a high of -$16.17 million in Q2 2023.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$22.56 million (Q1 2026), -$27.36 million (Q4 2025) and -$19.01 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Altimmune | 411.69 Mn | -730.54 Mn | - | -22.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -22.83 Mn |
| Mar 31, 2026 | -22.56 Mn |
| Dec 31, 2025 | -27.36 Mn |
| Sep 30, 2025 | -19.01 Mn |
| Jun 30, 2025 | -22.15 Mn |
| Mar 31, 2025 | -19.58 Mn |
| Dec 31, 2024 | -23.18 Mn |
| Sep 30, 2024 | -22.85 Mn |
| Jun 30, 2024 | -24.64 Mn |
| Mar 31, 2024 | -24.39 Mn |
| Dec 31, 2023 | -31.64 Mn |
| Sep 30, 2023 | -20.67 Mn |
| Jun 30, 2023 | -16.06 Mn |
| Mar 31, 2023 | -20.07 Mn |
| Dec 31, 2022 | -21.66 Mn |
| Sep 30, 2022 | -23.52 Mn |
| Jun 30, 2022 | -20.11 Mn |
| Mar 31, 2022 | -19.43 Mn |
| Dec 31, 2021 | -23.89 Mn |
| Sep 30, 2021 | -33.51 Mn |
API Access
Altimmune Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=ALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "ALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=ALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();